ABC
1Main
2BrandAMG 890, ARO-LPA
3Genericolpasiran
4IndicationCVD
5EconomicsLicensed to AMGN, sold royalty stake to RPRX
6MOAapolipoprotein A
7Clinical Trials
8Phase III outcomes study